JP2020508961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020508961A5 JP2020508961A5 JP2018547979A JP2018547979A JP2020508961A5 JP 2020508961 A5 JP2020508961 A5 JP 2020508961A5 JP 2018547979 A JP2018547979 A JP 2018547979A JP 2018547979 A JP2018547979 A JP 2018547979A JP 2020508961 A5 JP2020508961 A5 JP 2020508961A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- dose
- administered
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000008589 Obesity Diseases 0.000 claims description 6
- 235000020824 obesity Nutrition 0.000 claims description 6
- XFJAMQQAAMJFGB-ZQGJOIPISA-N (2s,3r,4r,5s,6r)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound C1=C(CC=2C=C3OCCOC3=CC=2)C(CC)=CC=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XFJAMQQAAMJFGB-ZQGJOIPISA-N 0.000 claims description 4
- 206010012735 Diarrhoea Diseases 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 208000016261 weight loss Diseases 0.000 claims description 4
- 230000004580 weight loss Effects 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 230000037396 body weight Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762466572P | 2017-03-03 | 2017-03-03 | |
| US62/466,572 | 2017-03-03 | ||
| PCT/IB2018/051350 WO2018158744A1 (en) | 2017-03-03 | 2018-03-02 | Sglt1/2 inhibitor lik066 for treating obesity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020508961A JP2020508961A (ja) | 2020-03-26 |
| JP2020508961A5 true JP2020508961A5 (https=) | 2021-03-18 |
Family
ID=61656084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018547979A Pending JP2020508961A (ja) | 2017-03-03 | 2018-03-02 | Ｓｇｌｔ１／２阻害剤の投与レジメン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10952989B2 (https=) |
| JP (1) | JP2020508961A (https=) |
| AR (1) | AR111161A1 (https=) |
| TW (1) | TW201834663A (https=) |
| WO (1) | WO2018158744A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8163704B2 (en) * | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| US8614195B2 (en) * | 2011-04-14 | 2013-12-24 | Novartis Ag | Glycoside derivatives and uses thereof |
-
2018
- 2018-03-02 US US16/490,554 patent/US10952989B2/en not_active Expired - Fee Related
- 2018-03-02 WO PCT/IB2018/051350 patent/WO2018158744A1/en not_active Ceased
- 2018-03-02 TW TW107107107A patent/TW201834663A/zh unknown
- 2018-03-02 AR ARP180100495A patent/AR111161A1/es unknown
- 2018-03-02 JP JP2018547979A patent/JP2020508961A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018193377A5 (https=) | ||
| JP2019509318A5 (https=) | ||
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| JP2015505564A5 (https=) | ||
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| JP2018513188A5 (https=) | ||
| JP2017533972A5 (https=) | ||
| JP2013541583A5 (https=) | ||
| JP2023116697A5 (https=) | ||
| RU2013127420A (ru) | Способы уменьшения психогенного или компульсивного переедания | |
| JP2020500864A5 (https=) | ||
| JP2008534503A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| JP2023531675A5 (https=) | ||
| RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
| RU2020120156A (ru) | Лечение приливов и потери костной ткани, вызванных андрогенной депривационной терапией с применением цис-кломифена | |
| JP2019531286A5 (https=) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi | |
| JP2019535830A5 (https=) | ||
| JP2023531930A5 (https=) | ||
| RU2013105513A (ru) | Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи | |
| JP2020508961A5 (https=) |